Summary
Isolation and growth of malignant cells from solid tumors have often met with disappointing results. Consequently, we have developed a cell culture methodology based on ex vivo explantation of tumor tissue, with subsequent monolayer cell outgrowth. In an attempt to assess methods for detection of malignant cells in these cultures, we analyzed and compared the results of cytopathology, growth in soft agar, and detection of telomerase activity with those of standard immunohistochemistry (IHC) techniques for the detection of cytokeratins, tumor marker p53, and proliferation marker Ki-67. The sensitivity of detection of malignant cells was 85% (22/26) for cytopathological examination, 30% (3/10) for soft agar growth, and 100% (12/12) for detection of telomerase activity. From these data, we concluded that both cytopathological examination and assessment of telomerase activity contribute to the detection of malignant cells in primary cultures of human solid tumors, whereas growth in soft agar was not a good indicator of malignant cells. Although not specific for malignant cells per se, IHC detection for epithelial cell cytokeratins showed a high degree of sensitivity (100%, 23/23), whereas the sensitivity for detection of tumor marker p53 and proliferation marker Ki-67 was 30% (7/23) and 70% (16/23), respectively. These data also provide proof that malignant tumor cells, derived from a diverse number of human solid tumors, can be isolated and grown in primary cell culture.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartek, J.; Bartkova, J.; Vojtesek, B., et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6(9):1699–1703; 1991.
Bergstraesser, L. M.; Weitzman, S. A. Culture of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type. Cancer Res. 53(11):2644–2654; 1993.
Blaheta, R. A.; Kronenberger, B.; Woitaschek, D., et al. Dedifferentiation of human hepatocytes by extracellular matrix proteins in vitro: quantitative and qualitative investigation of cytokeratin 7, 8, 18, 19 and vimentin filaments. J. Hepatol. 28(4):677–690; 1998.
Brower, M.; Carney, D. N.; Oie, H. K.; Gazdar, A. F.; Minna, J. D. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 46(2):798–806; 1986.
Croce, M. V.; Colussi, A. G.; Segal-Eiras, A. Assessment of methods for primary tissue culture of human breast epithelia. J. Exp. Clin. Cancer Res. 17(1):19–26; 1998.
Dairkee, S. H.; Paulo, E. C.; Traquina, P.; Moore, D. H.; Ljung, B. M.; Smith, H. S. Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells. Cancer Res. 57(8):1590–1596; 1997.
Ethier, S. P.; Mahacek, M. L.; Gullick, W. J.; Frank, T. S.; Weber, B. L. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res. 53(3):627–635; 1993.
Granger, M. P.; Wright, W. E.; Shay, J. W. Telomerase in cancer and aging. Crit. Rev. Oncol. Hematol. 41(1):29–40; 2002.
Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell 100(1):57–70; 2000.
Hiyama, E.; Hiyama, K.; Yokoyama, T.; Shay, J. W. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 3(1):17–26; 2001.
Hollstein, M.; Sidransky, D.; Vogelstein, B.; Harris, C. C., p53 mutations in human cancers. Science 253(5015):49–53; 1991.
Holt, S. E.; Wright, W. E.; Shay, J. W. Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 16(6):2932–2939; 1996.
Humason, G. L. Animal tissue techniques, San Francisco: W. H. Freeman; 1972;641.
Kim, N. W.; Piatyszek, M. A.; Prowse, K. R., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193):2011–2015; 1994.
Kirkels, W. J.; Pelgrim, O.E.; Hoogenboom, A.M.; Aalders, M.W.; Debruyne, F.M.; Vooijs, G. P.; Herman, C. J. Patterns of tumor colony development over time in soft-agar culture. Int. J. Cancer 32(4):399–406; 1983.
Kornblith, P. L. Role of tissue culture in prediction of malignancy. Clin. Neurosurg. 25:346–376; 1978.
Matthews, P.; Jones, C. J. Clinical implications of telomerase detection. Histopathology 38(6):485–498; 2001.
Moll, R.; Franke, W. W.; Schiller, D. L.; Geiger, B.; Krepler, R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31(1):11–24; 1982.
Ness, R. B.; Wisniewski, S. R.; Eng, H.; Christopherson, W. Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical response. Anticancer Res. 22(2B):1145–1149; 2002.
Papadopoulos, I.; Rudolph, P.; Wirth, B.; Weichert-Jacobsen, K. p53 expression, proliferation marker Ki-S5, DNA content and serum PSA: possible biopotential markers in human prostatic cancer. Urology 48(2):261–268; 1996.
Saalbach, A.; Aneregg, U.; Bruns, M.; Schnabel, E.; Herrmann, K.; Haustein, U. F. Novel fibroblast-specific monoclonal antibodies: properties and specificities. J. Invest. Dermatol. 106(6):1314–1319; 1996.
Scholzen, T.; Gerdes, J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182(3):311–322; 2000.
Shay, J. W.; Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33(5):787–791; 1997.
Shay, J. W.; Zou, Y.; Hiyama, E.; Wright, W. E. Telomerase and cancer. Hum. Mol. Genet. 10(7):677–685; 2001.
Speirs, V.; Green, A. R.; Walton, D. S.; Kerin, M. J.; Fox, J. N.; Carleton, P. J.; Desai, S. B.; Atkin, S. L. Short-term primary culture of epithelial cells derived from human breast tumours. Br. J. Cancer 78(11):1421–1429; 1998.
Taylor-Papadimitriou, J.; Stampfer, M.; Bartek, J.; Lewis, A.; Boshell, M.; Lane, E. B.; Leigh, I. M. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J. Cell Sci. 94(Pt. 3):403–413; 1989.
Wright, W. E.; Shay, J. W.; Piatyszek, M. A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23(18):3794–3795; 1995.
Yasunaga, Y.; Nakamura, K.; Ewing, C. M.; Isaacs, W. B.; Hukku, B.; Rhim, J. S. A novel human cell culture model for the study of familial prostate cancer. Cancer Res. 61(16):5969–5973; 2001.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ochs, R.L., Fensterer, J., Ohori, N.P. et al. Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors. In Vitro Cell.Dev.Biol.-Animal 39, 63–70 (2003). https://doi.org/10.1290/1543-706X(2003)039<0063:EFTIGA>2.0.CO;2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/1543-706X(2003)039<0063:EFTIGA>2.0.CO;2